BlackRock’s Picard Medical PMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14K Buy
13,489
+1,066
+9% +$1.55K ﹤0.01% 5364
2025
Q4
$21.7K Buy
+12,423
New +$58.5K ﹤0.01% 5204

Other funds holding PMI

BlackRock's PMI Position: Q1 2026 in Review

BlackRock increased its Picard Medical (PMI) stake by 8.6% in Q1 2026, buying an estimated $1.55K and bringing the position to 13,489 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #5364.

BlackRock first reported a position in PMI in Q4 2025 and has held it in 2 quarters since. The position peaked at $21.7K in Q4 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q1 2026.

  • BlackRock held 13,489 shares of Picard Medical worth $14K as of Q1 2026.
  • BlackRock bought 1,066 Picard Medical shares in Q1 2026, an estimated $1.55K.
  • Picard Medical made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5364 holding.
  • BlackRock first reported a position in Picard Medical in Q4 2025 and has held it in 2 quarters since.
  • BlackRock's Picard Medical position peaked at $21.7K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.